MoneyWorks4Me

Biocon informs about company statement

29 Jul 2026 Evaluate
Biocon has informed that it enclosed Company Statement with respect to ‘Biocon Receives Health Canada Approval for Yesintek® (ustekinumab) Autoinjector Pen’. The above information will also be available on the website of the Company at www.biocon.com. 

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1743.00
Dr. Reddys Labs. 1224.50
Cipla 1337.00
Lupin 1925.00
Zydus Lifesciences 1127.85
View more..